national antibiotic resistant organism (aro) infection ......cpe infection rates per 10,000 patient...

1
CNISP PCSIN CNISP PCSIN CNISP PCSIN National Antibiotic Resistant Organism (ARO) Infection Rates in Canadian Acute Care Hospitals participating in the Canadian Nosocomial Infection Surveillance Program (CNISP) Staphylococcus aureus (S. aureus) bacteria that are resistant to the antibiotic methicillin are known as Methicillin-resistant Staphylococcus aureus (MRSA). MRSA can cause bloodstream, skin and soft tissue, bone and lung infections, and left untreated, they can be life-threatening. Vancomycin-resistant Enterococci (VRE) are strains of enterococci bacteria that are resistant to the antibiotic vancomycin, an antibiotic generally prescribed to treat serious infections. VRE can cause infections such as urinary tract, surgical site and bloodstream infections. Gram-negative bacilli (GNB) cause a variety of infections, such as urinary tract, pneumonia and serious bloodstream or wound infections. GNB that have acquired resistance to carbapenems are called carbapenem-resistant gram-negative (CRGN) bacilli. Carbapenemase-producing Enterobacteriaceae (CPE) are a subset of CRGN bacilli which produce an enzyme that inactivates carbapenems, a last resort antibiotic. 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 2012 2013 2014 2015 2016 West Central East National HA-CDI RATES PER 10,000 PATIENT DAYS Rate per 10,000 patient days 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 2012 2013 2014 2015 2016 Rate per 10,000 patient days West Central East National MRSA INFECTION RATES PER 10,000 PATIENT DAYS 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 0.90 1.00 2012 2013 2014 2015 2016 Rate per 10,000 patient days West Central East National VRE INFECTION RATES PER 10,000 PATIENT DAYS 0.00 0.05 0.10 0.15 0.20 0.25 2012 2013 2014 2015 2016 Rate per 10,000 patient days West Central East National CPE INFECTION RATES PER 10,000 PATIENT DAYS MRSA VRE CPE Clostridium difficile (C. difficile) is a bacterium that causes diarrhea and is the most common cause of infectious diarrhea in hospital settings. Hospital-associated C. difficile infection (HA-CDI) can lead to complications requiring surgery or death. Adult or Mixed Adult/Pediatric Hospitals Pediatric Hospitals HA-CDI Geographic Location of CNISP Hospitals MRSA HA-CDI CPE VRE Infection prevention and control measures play a crucial role in helping to prevent the spread of these resistant organisms in healthcare settings.

Upload: others

Post on 02-Aug-2020

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: National Antibiotic Resistant Organism (ARO) Infection ......CPE INFECTION RATES PER 10,000 PATIENT DAYS MRSA INFECTION RATES PER 10,000 PATIENT DAYS HA-CDI RATES PER 10,000 PATIENT

CNISP PCSINCNISP PCSINCNISP PCSIN

National Antibiotic Resistant Organism (ARO) Infection Rates in Canadian Acute Care Hospitals participating in the Canadian Nosocomial Infection Surveillance Program (CNISP)

Staphylococcus aureus (S. aureus) bacteria that are resistant to the antibiotic methicillin

are known as Methicillin-resistant Staphylococcus aureus (MRSA). MRSA can cause bloodstream, skin and soft tissue, bone and lung infections, and left untreated, they can be life-threatening.

Vancomycin-resistant Enterococci (VRE) are strains of enterococci bacteria that are resistant to the antibiotic vancomycin, an antibiotic generally prescribed to treat serious infections. VRE can cause infections such as urinary tract, surgical site and bloodstream infections.

Gram-negative bacilli (GNB) cause a variety of infections, such as urinary tract, pneumonia and serious bloodstream or wound infections. GNB that have acquired resistance to carbapenems are called carbapenem-resistant gram-negative

(CRGN) bacilli. Carbapenemase-producing Enterobacteriaceae (CPE) are a subset of CRGN bacilli which produce an enzyme that inactivates carbapenems, a last resort antibiotic.

0.00

0.05

0.10

0.15

0.20

0.25

2012 2013 2014 2015 2016

Rat

e pe

r 10

,000

pat

ient

day

s

0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 0.90 1.00

2012 2013 2014 2015 2016

0.0

0.5

1.0

1.5

2.0

2.5

3.0

3.5

4.0

2012 2013 2014 2015 2016

0.0

1.0

2.0

3.0

4.0

5.0

6.0

7.0

8.0

2012 2013 2014 2015 2016

Rat

e pe

r 10

,000

pat

ient

day

s R

ate

per

10,0

00 p

atie

nt d

ays

West Central East National

West Central East National

West Central East National

West Central East National

VRE INFECTION RATES PER 10,000 PATIENT DAYS

CPE INFECTION RATES PER 10,000 PATIENT DAYS

MRSA INFECTION RATES PER 10,000 PATIENT DAYS

HA-CDI RATES PER 10,000 PATIENT DAYS

Rat

e pe

r 10

,000

pat

ient

day

s

0.00

0.05

0.10

0.15

0.20

0.25

2012 2013 2014 2015 2016

Rat

e pe

r 10

,000

pat

ient

day

s

0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 0.90 1.00

2012 2013 2014 2015 2016

0.0

0.5

1.0

1.5

2.0

2.5

3.0

3.5

4.0

2012 2013 2014 2015 2016

0.0

1.0

2.0

3.0

4.0

5.0

6.0

7.0

8.0

2012 2013 2014 2015 2016

Rat

e pe

r 10

,000

pat

ient

day

s R

ate

per

10,0

00 p

atie

nt d

ays

West Central East National

West Central East National

West Central East National

West Central East National

VRE INFECTION RATES PER 10,000 PATIENT DAYS

CPE INFECTION RATES PER 10,000 PATIENT DAYS

MRSA INFECTION RATES PER 10,000 PATIENT DAYS

HA-CDI RATES PER 10,000 PATIENT DAYS

Rat

e pe

r 10

,000

pat

ient

day

s

0.00

0.05

0.10

0.15

0.20

0.25

2012 2013 2014 2015 2016

Rat

e pe

r 10

,000

pat

ient

day

s

0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 0.90 1.00

2012 2013 2014 2015 2016

0.0

0.5

1.0

1.5

2.0

2.5

3.0

3.5

4.0

2012 2013 2014 2015 2016

0.0

1.0

2.0

3.0

4.0

5.0

6.0

7.0

8.0

2012 2013 2014 2015 2016

Rat

e pe

r 10

,000

pat

ient

day

s R

ate

per

10,0

00 p

atie

nt d

ays

West Central East National

West Central East National

West Central East National

West Central East National

VRE INFECTION RATES PER 10,000 PATIENT DAYS

CPE INFECTION RATES PER 10,000 PATIENT DAYS

MRSA INFECTION RATES PER 10,000 PATIENT DAYS

HA-CDI RATES PER 10,000 PATIENT DAYS

Rat

e pe

r 10

,000

pat

ient

day

s

0.00

0.05

0.10

0.15

0.20

0.25

2012 2013 2014 2015 2016

Rat

e pe

r 10

,000

pat

ient

day

s

0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 0.90 1.00

2012 2013 2014 2015 2016

0.0

0.5

1.0

1.5

2.0

2.5

3.0

3.5

4.0

2012 2013 2014 2015 2016

0.0

1.0

2.0

3.0

4.0

5.0

6.0

7.0

8.0

2012 2013 2014 2015 2016

Rat

e pe

r 10

,000

pat

ient

day

s R

ate

per

10,0

00 p

atie

nt d

ays

West Central East National

West Central East National

West Central East National

West Central East National

VRE INFECTION RATES PER 10,000 PATIENT DAYS

CPE INFECTION RATES PER 10,000 PATIENT DAYS

MRSA INFECTION RATES PER 10,000 PATIENT DAYS

HA-CDI RATES PER 10,000 PATIENT DAYS

Rat

e pe

r 10

,000

pat

ient

day

s

MRSA

VRE

CPE

Clostridium difficile (C. difficile) is a bacterium that causes diarrhea

and is the most common cause of infectious diarrhea in hospital settings. Hospital-associated C. difficile infection (HA-CDI) can lead to complications requiring surgery or death.

Adult or Mixed Adult/Pediatric HospitalsPediatric Hospitals

HA-CDI

Geographic Location of CNISP Hospitals

MRSA

HA-CDI

CPE

VRE

Infection prevention and control measures play a crucial role in helping to prevent the spread of these resistant organisms in healthcare settings.